SynthesisFrontiers in oncology2021

Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis.

Yuan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.